Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

AdvaMed’s Bailey Gets Makeover As Cosmetic Head; Swift Search Anticipated

This article was originally published in The Gray Sheet

Executive Summary

AdvaMed member companies who are not represented on the group's executive search committee are circulating a list of potential replacements for President Pam Bailey

You may also be interested in...



AdvaMed President Ubl Brings Detailed Policy Approach To Industry Agenda

The choice of Stephen Ubl as AdvaMed's president & CEO reflects board members' preference for detailed knowledge of the industry over mere political clout

AdvaMed President Ubl Brings Detailed Policy Approach To Industry Agenda

The choice of Stephen Ubl as AdvaMed's president & CEO reflects board members' preference for detailed knowledge of the industry over mere political clout

Grissom Exits Boston Scientific Beltway; Polymer Traffic To Continue

Boston Scientific VP-Federal Affairs, Reimbursement & Outcomes Planning Randel Richner will direct Washington, D.C. operations on a temporary basis, now that Tom Grissom has left the firm

Table

View full table

Tags:
Latest Headlines

News We’re Watching: Medtronic To Buy EOFLow, Neuralink Cleared For Human Trials, NICE Backs Genetic Tests

White House Takes Steps To Advance ‘Responsible’ AI That ‘Upholds Democratic Values’

UK MHRA Says Genetic Biobank Could Transform Drug Safety Monitoring Through Personalized Medicine

Wi-Fi Failures, Custom Tech And Other Challenges Of Bringing Specialty Care Into Patients’ Homes

See All
UsernamePublicRestriction

Register

MT021788

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By